Today: 9 April 2026
SoFi stock slips again as share-sale overhang hangs on; Jan. 30 earnings next
7 January 2026
1 min read

SoFi stock slips again as share-sale overhang hangs on; Jan. 30 earnings next

NEW YORK, Jan 7, 2026, 11:26 (EST) — Regular session

  • SoFi shares down about 1.4% mid-morning, lagging the broader market
  • Filing shows underwriters exercised option tied to December stock offering; total shares sold rose to 57.75 million
  • BofA restarted coverage at underperform, pointing to valuation and limited upside

SoFi Technologies shares were down about 1.4% at $26.61 by 11:26 a.m. EST on Wednesday, extending recent weakness as investors absorbed fresh details on stock sold into the market.

A regulatory filing showed the underwriters of SoFi’s December share sale exercised their option to buy additional stock, and the company completed that extra issuance on Jan. 5. The “greenshoe” option — a standard clause that lets banks buy more shares — pushed total shares sold in the offering to 57,754,660 at $27.50 each, with Goldman Sachs, BofA Securities, Citigroup, Deutsche Bank and Mizuho listed as underwriters. CloudFront

The added stock matters now because it lifts the number of shares in the market, diluting existing holders and often capping near-term gains as investors wait for demand to catch up with supply. Bank of America analyst Mihir Bhatia, restarting coverage with an underperform rating and a $20.50 price target, called the December capital raise a “modest positive” that gives SoFi “ammunition” to keep investing, but argued any acquisition is “likely to be smaller and more complementary than game changing.” TipRanks

SoFi’s drop came even as the broader tape was slightly higher, with the S&P 500 proxy SPY up about 0.1% and the tech-heavy QQQ up about 0.4%. Digital-lending peers were also lower, with Upstart down about 1.3% and LendingClub down about 1.6%.

Traders are treating the $27.50 offering price as a quick gut-check level. SoFi is now below it, which can keep sellers active if investors think more stock could surface from the deal’s after-effects.

The bigger question is what the company does with a thicker capital cushion. Investors have been looking for signs that SoFi will lean into lending growth, spend more to pull in deposits, or use the balance sheet for targeted deals, rather than chase a “big swing” transaction.

But the setup cuts both ways. If credit turns — particularly in unsecured consumer lending — losses can jump fast, and a market already sensitive to dilution could punish any hint that SoFi needs more capital or is taking on risk to keep growth running.

The next clear catalyst is SoFi’s fourth-quarter and full-year 2025 results, due Jan. 30 before the U.S. market opens, when investors will focus on loan growth, credit performance and any updated view on how the company plans to deploy capital. investors.sofi.com

Stock Market Today

  • Guard Therapeutics Faces Potential Delisting from Nasdaq First North Growth Market
    April 9, 2026, 12:06 PM EDT. Guard Therapeutics International AB has been notified by Nasdaq that it currently fails to meet the active operations requirement, risking delisting by June 17, 2026. The company is exploring a merger or reverse acquisition to satisfy Nasdaq's operational criteria. A transaction structure is expected to be proposed in Q2 2024, allowing Nasdaq to reassess the listing status. If no agreement is reached, the board will recommend voluntary delisting and liquidation, returning available funds to shareholders. Final decisions will be taken by shareholders at a general meeting. Guard Therapeutics focuses on developing therapies for kidney diseases based on the alpha-1-microglobulin protein and is listed under the ticker GUARD.

Latest article

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

9 April 2026
Palantir Technologies dropped about 7% Thursday after Michael Burry said Anthropic was overtaking it in enterprise AI, putting Palantir on track to lose $34 billion in market value. Anthropic reported its annualized revenue run rate had surged past $30 billion and launched new AI tools for businesses. Nearly one in four businesses on Ramp now pays for Anthropic, according to Ramp data. Palantir’s stock still trades at 395 times earnings.
Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

9 April 2026
Salesforce shares hit a new 52-week low Thursday, dropping 3.7% to $169.76 despite reporting 12% revenue growth and strong demand for its AI products. The broader software sector continued to slide, with the S&P 500 software and services index down about $1 trillion since January. Salesforce raised its buyback authorization to $50 billion and increased its dividend to 44 cents a share.
ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

9 April 2026
ServiceNow shares dropped 5.1% to $92.45 by 10:20 a.m. EDT Thursday, hitting a new 52-week low after analysts at Stifel, BTIG, and Goldman Sachs cut price targets citing weak federal spending and limited 2026 growth. The company announced it will integrate AI, data, security, and governance into all products ahead of first-quarter results due April 22.
SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

9 April 2026
SoFi Technologies shares fell 1.9% to $16.18 Thursday after KBW and Wells Fargo cut price targets ahead of first-quarter results due April 29. The moves follow Muddy Waters’ short position and claims of accounting issues, which SoFi denies. Affirm and LendingClub also traded lower. Barclays and other banks have trimmed targets as concerns mount over credit quality and sector valuations.
Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

9 April 2026
Tesla is developing a smaller, cheaper electric SUV to be built first in Shanghai, sources said. The new model would cost less than the Model 3 and be smaller than the Model Y. Tesla produced 408,386 vehicles but delivered only 358,023 in Q1, as U.S. demand weakened and competition increased. Shares fell 0.8% Thursday.
Abivax stock jumps 7% on Nasdaq — here’s what’s moving ABVX and what’s next
Previous Story

Abivax stock jumps 7% on Nasdaq — here’s what’s moving ABVX and what’s next

Regencell Bioscience stock jumps 27% again as RGC’s wild swings draw momentum traders
Next Story

Regencell Bioscience stock jumps 27% again as RGC’s wild swings draw momentum traders

Go toTop